Saturday 17 October 2026
Export LSDIF’s income statement to Excel — free account
Lucy Scientific Discovery Inc.
LSDIF Healthcare Drug Manufacturers Specialty & Generic
Operating cash flow growth for three consecutive years.
0.00
0.00
NaN
Follow LSDIF
| Older periods | Mar '23 | Jun '23 | Sep '23 | Dec '23 | |
|---|---|---|---|---|---|
|
+4 more TTM periods Free account |
0.00% | 0.00% | 631.10% | 337.20% | |
| (171.91%) | (204.78%) | (306.88%) | (249.36%) | ||
ROIC |
(111.14%) | (121.70%) | (168.15%) | 0.00% | |
Return on Tangible Assets |
(176.58%) | (478.87%) | (31,115.86%) | 526.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.23) | (3.33) | (3.26) | (3.60) | |
Free Cash Flow |
(0.32) | (4.23) | (5.73) | (6.35) | |
Capital Expenditures |
0.07 | 0.03 | (0.42) | (0.42) | |
| Other line items | |||||
Cash ROIC |
(3.39%) | (66.62%) | (194.98%) | (2,171.19%) | |
Accounts Receivable Turnover |
— | — | 0.00 | 0.00 | |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.05 | |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 4,445.77 | 3,262.41 | 4,581.20 | |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(2.11) | (1.49) | (1.83) | (5.01) | |
Operating CF/Net income |
0.05 | 0.47 | 0.55 | 0.52 | |
Depreciation/Fixed assets |
0.15 | 0.21 | 0.28 | 0.00 | |
Capex/Depreciation |
0.54 | 0.21 | (2.29) | (2.88) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.28) | (3.36) | (3.02) | (3.36) | |
Capex per Share |
0.05 | 0.03 | (0.24) | (0.24) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates